Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0UG8H
|
||||
| Former ID |
DNC014083
|
||||
| Drug Name |
SN-11
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530073] | ||
| Formula |
C27H28N2O
|
||||
| Canonical SMILES |
C1CC1CN2CCC34CC5=NC6=CC=CC=C6C=C5CC3C2CC7=C4C=C(C=C7)O
|
||||
| InChI |
1S/C27H28N2O/c30-21-8-7-18-13-26-23-12-20-11-19-3-1-2-4-24(19)28-25(20)15-27(23,22(18)14-21)9-10-29(26)16-17-5-6-17/h1-4,7-8,11,14,17,23,26,30H,5-6,9-10,12-13,15-16H2/t23-,26+,27+/m0/s1
|
||||
| InChIKey |
FTJYQAMRGYACMS-HUROMRQRSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [530073] | |
| Kappa-type opioid receptor | Target Info | Inhibitor | [530073] | ||
| Mu-type opioid receptor | Target Info | Inhibitor | [530073] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||